Direct stroke unit admission of intravenous tissue plasminogen activator: safety, clinical outcome, and hospital cost savings

Direct stroke unit admission of intravenous tissue plasminogen activator: safety, clinical outcome, and hospital cost savings

Background: In the USA, stable intravenous tissue plasminogen activator (IV tPA) patients have traditionally been cared for in an intensive care unit (ICU). We examined the safety of using an acuity-adaptable stroke unit (SU) to manage IV tPA patients. Methods: We conducted an observational study of...

Full description

Bibliographic Details
Main Authors: Anne W. Alexandrov, Kisha C. Coleman, Paola Palazzo, Reza Bavarsad Shahripour, Andrei V. Alexandrov
Format: Article
Language:English
Published: SAGE Publishing 2016-07-01
Series:Therapeutic Advances in Neurological Disorders
Online Access:https://doi.org/10.1177/1756285616648061

Internet

https://doi.org/10.1177/1756285616648061

Similar Items